Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane

Fabio Del Bello, Maria Vittoria Micioni Di Bonaventura, Alessandro Bonifazi, Bernhard Wünsch, Dirk Schepmann, Jolynn B. Giancola, Emanuela Micioni Di Bonaventura, Giulio Vistoli, Gianfabio Giorgioni, Wilma Quaglia, Alessandro Piergentili, Carlo Cifani

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

The enantiomers of the potent σ1 receptor antagonist (±)-1 were synthesized and evaluated for their affinity at σ1, σ2 receptors and dopamine transporter (DAT). Analogously to (±)-1, both of the enantiomers showed very high affinity for the σ1 receptor and unprecedented selectivity over both the σ2 receptor and DAT. The lack of enantioselectivity between (+)-1 and (-)-1 indicated that the center of chirality in the 2-position of the benzothiochromane nucleus does not play a crucial role in the interaction with any of the studied targets. Docking studies confirmed that the configuration of the enantiomers has only marginal effects on the molecular interactions with the σ1 receptor. In in vivo studies in a female rat model of binge eating, (±)-1 dose-dependently decreased the binge eating episode elicited by a history of intermittent food restriction and stress, confirming and strengthening the important role played by the σ1 receptor in bingeing-related eating disorders.

Original languageEnglish (US)
Pages (from-to)3391-3397
Number of pages7
JournalACS chemical neuroscience
Volume10
Issue number8
DOIs
StatePublished - Aug 21 2019
Externally publishedYes

Keywords

  • Selective σ antagonists
  • binge eating episode
  • chirality
  • docking studies
  • palatable food

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Cognitive Neuroscience
  • Cell Biology

Fingerprint

Dive into the research topics of 'Investigation of the Role of Chirality in the Interaction with σ Receptors and Effect on Binge Eating Episode of a Potent σ1 Antagonist Analogue of Spipethiane'. Together they form a unique fingerprint.

Cite this